This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2021;118(3):342-344.

doi: 10.1159/000514990. Epub 2021 Apr 1.

Stopping Trials Early: Responsibility and Risks

William McGuire¹, Henry L Halliday²

Affiliations

PMID: 33794539
DOI: 10.1159/000514990

Comment

Stopping Trials Early: Responsibility and Risks

William McGuire et al. Neonatology. 2021.

. 2021;118(3):342-344.

doi: 10.1159/000514990. Epub 2021 Apr 1.

Authors

William McGuire¹, Henry L Halliday²

Affiliations

¹ Centre for Reviews and Dissemination, University of York, York, United Kingdom.
² Queen's University, Belfast, United Kingdom.

PMID: 33794539
DOI: 10.1159/000514990

No abstract available

PubMed Disclaimer

Comment on

Early PARacetamol (EPAR) Trial: A Randomized Controlled Trial of Early Paracetamol to Promote Closure of the Ductus Arteriosus in Preterm Infants.
Schindler T, Smyth J, Bolisetty S, Michalowski J, Mallitt KA, Singla A, Lui K. Schindler T, et al. Neonatology. 2021;118(3):274-281. doi: 10.1159/000515415. Epub 2021 Apr 12. Neonatology. 2021. PMID: 33845473 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions

Grants and funding

DH_/Department of Health/United Kingdom

LinkOut - more resources

Full Text Sources
- S. Karger AG, Basel, Switzerland
Other Literature Sources
- scite Smart Citations